Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-10-02 Purchase | 2024-10-04 7:40 pm | Oncocyte Corp | OCX | James Andrea S. Chief Financial Officer | 33,670 | $2.97 | $100,000 | 33,670 (Direct) | View |
| 2024-10-02 Purchase | 2024-10-04 7:00 pm | Oncocyte Corp | OCX | BROADWOOD PARTNERS L.P. BROADWOOD CAPITAL INC BRADSHER NEAL C 10% Owner | 1,315,339 | $2.948 | $3,877,619 | 12,789,153 (Indirect Direct) | View |
| 2024-04-11 Purchase | 2024-04-15 7:21 pm | Oncocyte Corp | OCX | BROADWOOD PARTNERS L.P. BROADWOOD CAPITAL INC BRADSHER NEAL C 10% Owner | 2,420,000 | $2.9164 | $7,057,688 | 10,158,475 (Indirect Direct) | View |
| 2024-04-11 Purchase | 2024-04-15 06:04 am | Oncocyte Corp | OCX | Riggs Josh CEO and President | 3,390 | $2.95 | $10,001 | 3,505 (Direct) | View |
| 2024-04-11 Purchase | 2024-04-15 06:02 am | Oncocyte Corp | OCX | Arno Andrew Director | 33,898 | $2.95 | $99,999 | 84,662 (Indirect Direct) | View |
| 2023-06-14 Purchase | 2023-06-15 8:13 pm | Oncocyte Corp | OCX | KINGSLEY ALFRED D Director | 30,000 | $0.2149 | $6,447 | 563,223 (Indirect Direct) | View |
| 2023-04-05 Purchase | 2023-04-07 5:12 pm | Oncocyte Corp | OCX | PURA VIDA INVESTMENTS LLC Kamen Efrem 10% Owner | 663,000 | $0.3017 | $200,027 | 14,829,163 (Indirect) | View |
| 2023-04-03 Purchase | 2023-04-05 9:35 pm | Oncocyte Corp | OCX | BROADWOOD PARTNERS L.P. BROADWOOD CAPITAL INC BRADSHER NEAL C 10% Owner | 26,827,638 | $0.3017 | $8,093,898 | 112,385,084 (Indirect Direct) | View |
| 2022-12-23 Purchase | 2022-12-28 4:05 pm | Oncocyte Corp | OCX | Arno Andrew Director | 250,000 | $0.3515 | $87,875 | 562,049 (Indirect Direct) | View |
| 2022-12-23 Purchase | 2022-12-28 4:05 pm | Oncocyte Corp | OCX | Gutfreund John Peter Director | 75,000 | $0.3297 | $24,728 | 75,000 (Indirect) | View |
| 2022-12-22 Purchase | 2022-12-27 6:47 pm | Oncocyte Corp | OCX | KINGSLEY ALFRED D Director | 25,000 | $0.285 | $7,125 | 533,223 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-10-11 Option Award | 2024-10-15 4:15 pm | N/A 2034-06-20 | Oncocyte Corp | OCX | James Andrea S. Chief Financial Officer | 300,000 | $0 | 300,000 (Direct) | View |
| 2024-07-01 Option Award | 2024-07-03 9:00 pm | N/A 2034-07-01 | Oncocyte Corp | OCX | Arno Andrew Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2024-07-01 Option Award | 2024-07-03 9:00 pm | N/A 2034-07-01 | Oncocyte Corp | OCX | Last Andrew J. Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2024-07-01 Option Award | 2024-07-03 9:00 pm | N/A 2034-07-01 | Oncocyte Corp | OCX | SILVERMAN LOU Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2024-06-20 Option Award | 2024-06-24 4:49 pm | N/A N/A | Oncocyte Corp | OCX | James Andrea S. Chief Financial Officer | 300,000 | $0 | 500,000 (Direct) | View |
| 2024-05-20 Option Award | 2024-05-22 5:18 pm | N/A 2034-05-20 | Oncocyte Corp | OCX | Liu James Yang Sr Dir., Cntlr, PAO, Int PFO | 10,000 | $0 | 10,000 (Direct) | View |
| 2024-05-20 Option Award | 2024-05-22 4:58 pm | N/A 2034-05-20 | Oncocyte Corp | OCX | Arno Andrew Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2024-05-20 Option Award | 2024-05-22 4:56 pm | N/A 2034-05-20 | Oncocyte Corp | OCX | Riggs Josh CEO and President | 90,000 | $0 | 90,000 (Direct) | View |
| 2024-04-15 Other | 2024-04-15 7:21 pm | N/A N/A | Oncocyte Corp | OCX | BROADWOOD PARTNERS L.P. BROADWOOD CAPITAL INC BRADSHER NEAL C 10% Owner | 2,941 | $0 | 10,158,475 (Direct) | View |
| 2023-10-10 Option Award | 2023-10-12 4:30 pm | N/A 2033-10-10 | Oncocyte Corp | OCX | Liu James Yang Sr Dir Controller PAO Int PFO | 8,482 | $0 | 8,482 (Direct) | View |
| 2023-08-15 Option Award | 2023-08-17 6:57 pm | N/A 2033-08-15 | Oncocyte Corp | OCX | Riggs Josh CEO and President | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-06-30 Other | 2023-07-03 6:00 pm | N/A 2027-04-19 | Oncocyte Corp | OCX | Gutfreund John Peter Former Director Director | 6,649,775 | $0 | 7,941,914 (Indirect) | View |
| 2023-06-23 Option Award | 2023-06-27 9:30 pm | N/A 2033-06-23 | Oncocyte Corp | OCX | Arno Andrew Director | 165,000 | $0 | 1,150,301 (Direct) | View |
| 2023-06-23 Option Award | 2023-06-27 9:30 pm | N/A 2033-06-23 | Oncocyte Corp | OCX | Last Andrew J. Director | 110,000 | $0 | 180,170 (Direct) | View |
| 2023-06-23 Option Award | 2023-06-27 9:30 pm | N/A 2033-06-23 | Oncocyte Corp | OCX | KINGSLEY ALFRED D Director | 110,000 | $0 | 673,223 (Direct) | View |
| 2023-06-23 Option Award | 2023-06-27 9:30 pm | N/A 2033-06-23 | Oncocyte Corp | OCX | SILVERMAN LOU Director | 137,500 | $0 | 143,770 (Direct) | View |
| 2023-06-09 Option Award | 2023-06-13 4:05 pm | N/A 2033-06-09 | Oncocyte Corp | OCX | Riggs Josh CEO and President | 1,150,000 | $0 | 1,150,000 (Direct) | View |
| 2023-03-06 Other(A) | 2023-04-18 6:49 pm | 2022-04-19 2027-04-19 | Oncocyte Corp | OCX | PURA VIDA INVESTMENTS LLC Kamen Efrem 10% Owner | 4,331,075 | $0 | 20,481,163 (Indirect) | View |
| 2023-04-03 Option Award | 2023-04-05 9:30 pm | N/A N/A | Oncocyte Corp | OCX | Gutfreund John Peter Director | 1,705,000 | $0.3544 | 1,790,000 (Direct) | View |
| 2023-04-03 Disposition | 2023-04-05 9:30 pm | N/A 2024-04-08 | Oncocyte Corp | OCX | Gutfreund John Peter Director | 588 | $0 | 1,790,000 (Direct) | View |
| 2023-04-03 Option Award | 2023-04-05 9:29 pm | N/A N/A | Oncocyte Corp | OCX | Arno Andrew Director | 141,084 | $0.3544 | 829,217 (Direct) | View |
| 2023-03-06 Other | 2023-03-08 8:54 pm | N/A N/A | Oncocyte Corp | OCX | PURA VIDA INVESTMENTS LLC Kamen Efrem 10% Owner | 3,890,111 | $0 | 18,056,274 (Indirect) | View |
| 2023-02-24 Option Award | 2023-02-28 5:59 pm | N/A 2033-02-24 | Oncocyte Corp | OCX | Riggs Josh CEO | 116,426 | $0 | 116,426 (Direct) | View |
| 2023-02-24 Option Award | 2023-02-28 5:55 pm | N/A 2033-02-24 | Oncocyte Corp | OCX | John Anish M. Chief Financial Officer | 121,381 | $0 | 121,381 (Direct) | View |
| 2023-01-17 Option Award | 2023-01-19 5:18 pm | N/A 2033-01-17 | Oncocyte Corp | OCX | Riggs Josh Interim CEO | 257,485 | $0 | 257,485 (Direct) | View |
| 2023-01-17 Option Award | 2023-01-19 5:16 pm | N/A 2033-01-17 | Oncocyte Corp | OCX | Liu James Yang Controller, PAO | 57,065 | $0 | 57,065 (Direct) | View |
| 2023-01-17 Option Award | 2023-01-19 5:14 pm | N/A 2033-01-17 | Oncocyte Corp | OCX | John Anish M. Chief Financial Officer | 250,466 | $0 | 250,466 (Direct) | View |
| 2022-12-21 Option Award | 2022-12-22 6:57 pm | N/A N/A | Oncocyte Corp | OCX | Ross Douglas T. Former CSO | 213,797 | $0 | 234,114 (Direct) | View |
| 2022-12-16 Disposition | 2022-12-20 4:05 pm | N/A N/A | Oncocyte Corp | OCX | Ross Douglas T. Former CSO. | 576,772 | $0 | 298,545 (Direct) | View |